GlaxoSmithKline

    By Bruce Watson

    | 11:00AM 9/22/2011
    Last week, TV host Dr. Mehmet Oz took on apple juice, declaring that the classic drink may be slowly poisoning America's children with arsenic. But the FDA and the juice companies have credibly refuted his claims. So was Dr. Oz's announcement meant to be a legitimate health warning, or just a cynical attempt to boost ratings?

    By The Associated Press

    | 7:15PM 3/09/2011
    0
    The Food and Drug Administration on Wednesday approved the first new drug to treat lupus in 56 years. It's not terribly effective: It only worked for 35% of the patients tested. But experts say the approval could prompt the development of more effective drugs.

    By Bruce Watson

    | 1:30PM 3/02/2011
    While painful (for most folks) to watch, the actor's explosion has created a bonanza for the tabloid mill. But on a broader level, Sheen has also offers a potential shot in the arm for companies across the spectrum, from media to pharmaceuticals. Hey Viacom, how about Charlie's Family?

    By Abigail Field

    | 12:00PM 1/24/2011
    Did GlaxoSmithKline's blockbuster diabetes drug Avandia cause fatal heart attacks? The first federal trial of an Avandia lawsuit began this morning in Philidelphia. As many as 50,000 more lurk in the wings.

    By Ira Teinowitz

    | 3:00PM 10/27/2010
    After years of American drugmakers touting the benefits of U.S. drugs and warning about buying cheaper drugs from somewhere else, a major U.S. drugmaker is admitting that some of its drugs may not have been so good after all. In what was a revealing and embarrassing admission, GlaxoSmithKline...

    By Dawn Kawamoto

    | 8:00PM 9/23/2010
    GlaxoSmithKline's Avandia diabetes drug got hit with a double whammy from regulators on both sides of the pond Thursday. The European Medicines Agency announced plans to yank the drug from the market in the coming months, while U.S. officials placed greater restrictions on its use.

    By Melly Alazraki

    | 12:36PM 9/20/2010
    Shares of Swiss pharmaceutical company Novartis were up about 1.5% in morning trading Monday following its announcement over the weekend that its Onbrez Breezhaler was found to be more effective at treating lung disease than a standard medicine from GlaxoSmithKline.

    By Abigail Field

    | 1:08AM 7/30/2010
    In a case that tested the boundaries of the Supreme Court's recent expansion of Second Amendment gun rights, the Third Circuit Court of Appeals ruled that some limits still apply: A federal law banning the possession of a gun with an obliterated serial number is constitutional, the court said.

    By Gergana Koleva

    | 4:00PM 7/19/2010
    The U.S. Food and Drug Administration warns that more than 25,000 asthma inhalers stolen last year from a pharmaceutical warehouse in Virginia have worked their way to pharmacy shelves and may not be safe or effective. The Advair Diskus inhalers, manufactured by GlaxoSmithKline, were stolen from a...

    By Linda Doell

    | 11:30AM 7/15/2010
    GlaxoSmithKline's diabetes drug Avandia should remain on the market but with new restrictions due to possible heart risks, says a federal panel of health experts. The U.S. Food and Drug Administration advisers voted 20-12 to keep the medicine available -- 10 panelists also recommended limiting who...